OSRH · OSR Health, Inc.
$0.42
-0.03 (-6.69%)
At close · Jul 24
Market Cap
$15.80M
Shares
35.10M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.45
Open$0.44
Day$0.43–0.45
52W$0.30–1.24
Avg vol 30d748K
Short int1.7M · 4.8% float · 2.0d
Short vol48%
DataMar 2023–Jul 2026
Filing10-Q · May 13
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−17%
below
Price vs 50-day avg
+7%
above
RSI (14)
60
neutral
MACD trend
Positive
52-week position
16%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+34%
trailing
6-month return
−30%
trailing
YTD return
−20%
this year
Relative strength
−37%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
1 of 11 funds reported for Jun 30 · net +60 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.82% of float · ▲ +19.5% MoM · 2.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
11 holders — near 1-yr high, broad support
Squeeze score
61
elevated · 0–100
Fundamentals
Revenue growth
−18%
Y/Y
Gross margin
20%
contracting
EPS growth
+83%
Y/Y
Balance sheet
$813.0K
net debt
Quant / Vol
risk profile
Volatility
150%
annualized · 1-yr
Max drawdown
−70%
past year
ATR
8.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−17%
Bearish
Price vs 50-day avg
+7%
Bullish
RSI (14)
60
Neutral
MACD trend
Positive
Bullish
52-week position
16%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
1 of 11 funds reported for Jun 30 · net +60 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
4.82% of float · ▲ +19.5% MoM · 2.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
11 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $0
Now $0 · 16%
52-wk high $1
vs 200-day avg -17%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSRH
this stock
OSR Health, Inc.
|
$15.80M | -20.2% | -17.7% | — | 4.8% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSRH | -7.4% | +33.5% | -30.2% | +42.4% | -20.2% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -5.7% | +32.9% | -36.6% | +43.6% | -28.5% |